Results 341 to 350 of about 458,722 (380)
Some of the next articles are maybe not open access.
Tobacco Smoking, Nicotine, and Nicotine and Non-Nicotine Replacement Therapies
Heart Disease, 2001Tobacco smoking is associated with an increased risk for the development of coronary and pulmonary vascular diseases and smoking cessation will greatly reduce this risk. Nicotine replacement and nonnicotine modalities have been used alone and in combination to help in smoking cessation.
Anjum Ismail +2 more
openaire +3 more sources
Chronopharmacokinetics of nicotine*
Clinical Pharmacology & Therapeutics, 1996For high-clearance drugs such as nicotine, hemodynamic changes throughout the day may be expected to influence the rate of metabolism.To assess the effects of meals and diurnal rhythms on nicotine clearance, an intravenous infusion of nicotine bitartrate was administered for 48 hours to 11 subjects.
Davide Verotta +2 more
openaire +3 more sources
Cochrane Database of Systematic Reviews, 2004
The proportion of people with schizophrenia who smoke is very high, and as a rule, they tend to be heavier smokers when compared to the general population and those with other psychiatric disorders. Nicotine, the psychoactive component in tobacco, is thought to produce psychological effects that help to alleviate psychotic symptoms.To examine the ...
Sumir Punnoose, Madhvi R Belgamwar
openaire +3 more sources
The proportion of people with schizophrenia who smoke is very high, and as a rule, they tend to be heavier smokers when compared to the general population and those with other psychiatric disorders. Nicotine, the psychoactive component in tobacco, is thought to produce psychological effects that help to alleviate psychotic symptoms.To examine the ...
Sumir Punnoose, Madhvi R Belgamwar
openaire +3 more sources
Nicotine & Tobacco Research, 2020
The single dose pharmacokinetics of a novel, non-tobacco-based nicotine pouch, ZYN®, 3 and 6 mg, were compared to 8 mg General snus (Part 1) and ZYN® 8 mg was compared to 18 mg Longhorn moist snuff (Part 2).
E. Lunell +3 more
semanticscholar +1 more source
The single dose pharmacokinetics of a novel, non-tobacco-based nicotine pouch, ZYN®, 3 and 6 mg, were compared to 8 mg General snus (Part 1) and ZYN® 8 mg was compared to 18 mg Longhorn moist snuff (Part 2).
E. Lunell +3 more
semanticscholar +1 more source
Chemischer Informationsdienst, 1979
Abstract(i)‐Nicotin (I) wird durch Verwendung von D‐Weinsäure und anschlie‐ βend Di‐p‐toluoyl‐L‐weinsäure in optisch reines (+)‐Nicotin gespalten.
Thomas J. Bradshaw +8 more
openaire +4 more sources
Abstract(i)‐Nicotin (I) wird durch Verwendung von D‐Weinsäure und anschlie‐ βend Di‐p‐toluoyl‐L‐weinsäure in optisch reines (+)‐Nicotin gespalten.
Thomas J. Bradshaw +8 more
openaire +4 more sources
Nicotine arms race: JUUL and the high-nicotine product market
Tobacco Control, 2019Objective Until recently, purveyors of vaping products marketed e-liquids in the 1%–3% range of nicotine concentration with those at 3% described as ‘super high’ intended for two packs/day smokers.
R. Jackler, Divya Ramamurthi
semanticscholar +1 more source